PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19110234-7 2009 CONCLUSION: Azacitidine enhanced the sensitivity of platinum-resistant ovarian cancer cells to carboplatin associated with caspase-3- and -8-dependent apoptosis pathway and reexpression of DR4. Platinum 52-60 caspase 3 Homo sapiens 123-140 18193228-8 2008 PT-262 induced the loss of mitochondrial membrane potential and elevated the caspase-3 activation and apoptosis. Platinum 0-2 caspase 3 Homo sapiens 77-86 18719365-5 2008 Further analysis revealed that the sensitization of platinums was associated with platinums-induced suppression of nuclear factor-kappaB (NFkappaB) and subsequent downregulation of X-linked inhibitor of apoptosis protein (XIAP), which rescued caspase-3 from inhibition. Platinum 52-61 caspase 3 Homo sapiens 243-252 18719365-5 2008 Further analysis revealed that the sensitization of platinums was associated with platinums-induced suppression of nuclear factor-kappaB (NFkappaB) and subsequent downregulation of X-linked inhibitor of apoptosis protein (XIAP), which rescued caspase-3 from inhibition. Platinum 82-91 caspase 3 Homo sapiens 243-252 12499281-7 2002 Concomitant platinum treatment and IR led to poly(ADP-ribose) polymerase cleavage as a sign of caspase-3 activation and apoptosis. Platinum 12-20 caspase 3 Homo sapiens 95-104 9380409-3 1997 Here we show that induction of PT is sufficient to activate CPP32-like proteases with DEVDase activity and the associated cleavage of the nuclear DEVDase substrate poly(ADP-ribose) polymerase (PARP). Platinum 31-33 caspase 3 Homo sapiens 60-65 34794242-0 2021 The endocytic pathway of Pt nanoclusters and their induced apoptosis of A549 and A549/Cis cells through c-Myc/p53 and Bcl-2/caspase-3 signaling pathways. Platinum 25-27 caspase 3 Homo sapiens 124-133 24169734-10 2014 The activity of the apoptosis-promoting protein caspase 3/7 was determined; results proved that these novel platinum compounds, under the chosen experimental conditions, preferentially induce apoptosis over necrosis. Platinum 108-116 caspase 3 Homo sapiens 48-57 33689300-4 2021 The polymer encapsulated a platinum intercalator (56MESS, (5,6-dimethyl-1,10-phenanthroline) (1S,2S-diaminocyclohexane) platinum(II)) and was conjugated with both a cell-targeting RGD peptide and a caspase-3 cleavable peptide probe to form nanoparticles for simultaneous NIR-II and apoptosis imaging. Platinum 27-35 caspase 3 Homo sapiens 198-207 32309901-0 2020 Platinum nanoparticles induced genotoxicity and apoptotic activity in human normal and cancer hepatic cells via oxidative stress-mediated Bax/Bcl-2 and caspase-3 expression. Platinum 0-8 caspase 3 Homo sapiens 152-161 32900227-9 2021 In addition, overexpression of pro-apoptotic (Bax) protein, caspase-3 activity and histone release were increased after treatment of both cell lines with different PT concentrations. Platinum 164-166 caspase 3 Homo sapiens 60-69 30826588-5 2019 The coumarin platinum(IV) complex could effectively induce apoptosis of SKOV-3 cells through up-regulating the expression of caspase3 and caspase9. Platinum 13-21 caspase 3 Homo sapiens 125-133 22568453-0 2012 Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy. Platinum 129-137 caspase 3 Homo sapiens 15-20 22039334-8 2011 Importantly, both cerium oxide and platinum nanoparticles reduce oxidant-mediated apoptosis in target cells as judged by the activation of caspase 3. Platinum 35-43 caspase 3 Homo sapiens 139-148 20517311-6 2010 The combination of YM155 and platinum compounds also induced synergistic increases both in the number of apoptotic cells and in the activity of caspase-3. Platinum 29-37 caspase 3 Homo sapiens 144-153